Details about PhD Scholarship Novel Complementary Diagnostics for Improved Therapeutics/Theranostics 2020
PhD Scholarship Novel Complementary Diagnostics for Improved Therapeutics/Theranostics 2020 is offered for PhD degree in the field of Engineering and Computing, Medicine, Science and Mathematics. You can apply to this scholarship here. The deadline for the sending your application is 23 Sep 2020. This scholarship is provided by University of Queensland (UQ) and the value of this scholarship is Partial Funding, AUD 34,013 per annum . This scholarship is open for: Open to domestic students.
- Degree: PhD
- Provided by: University of Queensland (UQ)
- Deadline: 23 Sep 2020
- Scholarship value: Partial Funding, AUD 34,013 per annum
A PhD studentship is available, commencing January 2021 based at the Centre for Advanced Imaging. This studentship is one of four being offered by The University of Queensland and the University of Nottingham and will include a research exchange programme. The studentship will deliver significant improvements in medical imaging/treatment by the co‑application of a range of biomedical imaging modalities.
Eligibility for PhD Scholarship Novel Complementary Diagnostics for Improved Therapeutics/Theranostics 2020:
- have completed some research experience
- have completed an approved university degree and
- can meet the English language requirements.
Value of PhD Scholarship Novel Complementary Diagnostics for Improved Therapeutics/Theranostics 2020:
- Provides AUD 34,013 per annum (2020 rate), indexed annually.
Applications will be judged on a competitive basis taking into account the applicant’s previous academic record, publication record, honors and awards, and employment history. Working knowledge of chemistry, engineering, physics, biology, or other related scientific disciplines would be of benefit to someone working on this project.
Our Scholarship team will help you with any questions
Kindly login to comment and ask your questions about PhD Scholarship Novel Complementary Diagnostics for Improved Therapeutics/Theranostics 2020